139 related articles for article (PubMed ID: 29606572)
1. Study of the structure-activity relationship of polymyxin analogues.
Kinoshita Y; Yakushiji F; Matsui H; Hanaki H; Ichikawa S
Bioorg Med Chem Lett; 2018 Sep; 28(16):2713-2716. PubMed ID: 29606572
[TBL] [Abstract][Full Text] [Related]
2. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
[TBL] [Abstract][Full Text] [Related]
3. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
[TBL] [Abstract][Full Text] [Related]
4. Total and Semisyntheses of Polymyxin Analogues with 2-Thr or 10-Thr Modifications to Decipher the Structure-Activity Relationship and Improve the Antibacterial Activity.
Li J; Guan D; Chen F; Shi W; Lan L; Huang W
J Med Chem; 2021 May; 64(9):5746-5765. PubMed ID: 33909428
[TBL] [Abstract][Full Text] [Related]
5. Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity.
Brown P; Abdulle O; Boakes S; Duperchy E; Moss S; Simonovic M; Stanway S; Wilson A; Dawson MJ
Bioorg Med Chem Lett; 2020 Jun; 30(11):127163. PubMed ID: 32273214
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity.
Vaara M; Vaara T; Tyrrell JM
Peptides; 2017 May; 91():8-12. PubMed ID: 28300674
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of polymyxin B1 and analogues via a safety-catch approach.
de Visser PC; Kriek NM; van Hooft PA; Van Schepdael A; Filippov DV; van der Marel GA; Overkleeft HS; van Boom JH; Noort D
J Pept Res; 2003 Jun; 61(6):298-306. PubMed ID: 12753377
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on novel polymyxin derivatives that carry only three positive charges.
Vaara M; Vaara T
Peptides; 2010 Dec; 31(12):2318-21. PubMed ID: 20868714
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin derivatives as broad-spectrum antibiotic agents.
Su M; Wang M; Hong Y; Nimmagadda A; Shen N; Shi Y; Gao R; Zhang E; Cao C; Cai J
Chem Commun (Camb); 2019 Oct; 55(87):13104-13107. PubMed ID: 31612170
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance.
Han ML; Velkov T; Zhu Y; Roberts KD; Le Brun AP; Chow SH; Gutu AD; Moskowitz SM; Shen HH; Li J
ACS Chem Biol; 2018 Jan; 13(1):121-130. PubMed ID: 29182311
[TBL] [Abstract][Full Text] [Related]
11. A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.
Velkov T; Yun B; Schneider EK; Azad MA; Dolezal O; Morris FC; Nation RL; Wang J; Chen K; Yu HH; Wang L; Thompson PE; Roberts KD; Li J
ACS Infect Dis; 2016 May; 2(5):341-51. PubMed ID: 27627202
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimicrobial studies of some polymyxin analogues.
Tang H; Zhang Y; Ma J; Dong Y; Gao Q; Feng J
J Antibiot (Tokyo); 2020 Mar; 73(3):158-166. PubMed ID: 31831870
[TBL] [Abstract][Full Text] [Related]
13. [Growth inhibition zones between polymyxin and sulphonamides].
Breitfellner G
Zentralbl Bakteriol Orig A; 1972 Aug; 221(3):357-66. PubMed ID: 4146475
[No Abstract] [Full Text] [Related]
14. Synthesis of triazole-functionalized 2-DOS analogues and their evaluation as A-site binders.
Anastasopoulou P; Kythreoti G; Cosmidis T; Pyrkotis C; Nahmias VR; Vourloumis D
Bioorg Med Chem Lett; 2014 Feb; 24(4):1122-6. PubMed ID: 24440302
[TBL] [Abstract][Full Text] [Related]
15. Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.
Yun B; Azad MA; Nowell CJ; Nation RL; Thompson PE; Roberts KD; Velkov T; Li J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7489-96. PubMed ID: 26392495
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combinations of polymyxins.
Lenhard JR; Nation RL; Tsuji BT
Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
18. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
Brown P; Dawson MJ
J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Polymyxin-Like Antibiotics.
Velkov T; Roberts KD
Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.
Magee TV; Brown MF; Starr JT; Ackley DC; Abramite JA; Aubrecht J; Butler A; Crandon JL; Dib-Hajj F; Flanagan ME; Granskog K; Hardink JR; Huband MD; Irvine R; Kuhn M; Leach KL; Li B; Lin J; Luke DR; MacVane SH; Miller AA; McCurdy S; McKim JM; Nicolau DP; Nguyen TT; Noe MC; O'Donnell JP; Seibel SB; Shen Y; Stepan AF; Tomaras AP; Wilga PC; Zhang L; Xu J; Chen JM
J Med Chem; 2013 Jun; 56(12):5079-93. PubMed ID: 23735048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
